title: Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.
abstract: Previous studies have demonstrated that prior infection by various bacterial pathogens induces nonspecific resistance to subsequent infection by other gram-negative and gram-positive bacterial pathogens. In the present study, we evaluated whether underlying inflammation enhanced host resistance to inhalational Bacillus anthracis infection in New Zealand White rabbits (SPF; Bordetella- and Pasteurella-free). Accordingly, rabbits were pretreated with either the inflammagen bacterial LPS (60,000 EU/kg), a component of the outer membrane of gram-negative bacteria, or saline (vehicle). Administration of LPS resulted in brief pyrexia and a significant increase in the proinflammatory cytokine TNFα, thus confirming LPS-induced inflammation. At 24 h after LPS treatment, rabbits were exposed to aerosolized B. anthracis spores (Ames strain; approximately 300 LD50). Blood samples collected at various times after challenge were cultured. Compared with their saline-pretreated counterparts, LPS-pretreated, B. anthracis challenged rabbits exhibited delays in 2 biomarkers of B. anthracis infection-anthrax-induced pyrexia (25 h versus 66 h after challenge, respectively) and bacteremia (26 h versus 63 h, respectively)-and survived longer (41 h versus 90 h, respectively). Similar to control animals, all LPS-pretreated, B. anthracis-challenged rabbits exhibited pathology consistent with inhalational anthrax. Taken together, these results suggest that prior or underlying stimulation of the innate immune system induces transient host resistance to subsequent B. anthracis infection in SPF New Zealand white rabbits. In particular, our results emphasize the importance of using animals that are free of underlying infections to prevent confounding data in studies for inhalational anthrax characterization and medical countermeasure evaluation.
authors.affiliation: Center for Aerobiological Sciences, United States Army Medical Institute of Infectious Diseases, Fort Detrick, Maryland, USA. steven.yee@us.army.mil
authors.forename: Steven B
authors.initials: SB
authors.lastname: Yee
authors.forename: David N
authors.initials: DN
authors.lastname: Dyer
authors.forename: Nancy A
authors.initials: NA
authors.lastname: Twenhafel
authors.forename: M Louise M
authors.initials: ML
authors.lastname: Pitt
mesh_terms: D000336:Aerosols; D000818:Animals; D000881:Anthrax / Q000517:prevention & control*; D001408:Bacillus anthracis / Q000472:pathogenicity* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D007928:Lethal Dose 50; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008297:Male; D011817:Rabbits; D013171:Spores, Bacterial
chemical_list: D000336:Aerosols; D008070:Lipopolysaccharides